0
0
0
s2sdefault

“Combustion is the issue, not nicotine,” said Philip Morris International Chief Executive Officer André Calantzopoulos while referring to the recent US Food and Drug Administration’s (FDA) authorization to market IQOS as a Modified Risk Tobacco Product (MRTP) with reduced exposure claims.

During a virtual press briefing held recently, Calantzopoulos said the US FDA “recognizes that better alternatives do exist because they are all non-combustibles. It articulates very clearly, combustion is the issue.”